At 6.8% CAGR, Antiviral Drug Resistance Market is Projected to Surpass US$ 4,573.24 million by 2027 Rise in Prevalence of Virus infections such as Hepatitis Diseases to Drive the Market | Trinity Biotech, AccuBioTech Co., Ltd., and ACON Laboratories, Inc.

The antiviral drug resistance market was valued at US$ 2,572.26 million in 2018 and it is projected to reach US$ 4,573.24 million in 2027; it is expected to grow at a CAGR of 6.8% from 2019 to 2027.

Antiviral drug resistance refers to decreased susceptibility towards a drug which occurs due to changes in viral genotypes. During instances of antiviral resistance, the drugs have either lost their effectiveness or have been diminished against the virus to be targeted. Antiviral drug resistance is a rising concern among immune-compromised patients. The growth of the global antiviral drug resistance market is attributed to the rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS.

A new market report by The Insight Partners on the Antiviral Drug Resistance Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and shares in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies.

The prevalence of virus infections such as hepatitis has increased during recent years across the globe. Hepatitis causes liver damage and inflammation that can also damage other organs. It is a major global health problem that can cause chronic infection and also upsurge the higher risk of death from cirrhosis and liver cancer.

Get Sample PDF at: https://bit.ly/3zp1Hg6

The market for antiviral drug resistance is expected to grow, owing to factors such as rise in the incidences of hepatitis diseases and increasing prevalence of HIV/AIDS. In addition, increasing healthcare expenditures in emerging markets is likely to have a positive impact on the growth of the market in the coming years. Hepatitis can be categorized as hepatitis A, B, C, D, and E that spread through different causes. According to the WHO (World Health Organization), the prevalence of Hepatitis B is the highest in the African and Western Pacific Region, where 6.1% and 6.2% of the adult population is infected respectively.

Key companies Included in Antiviral Drug Resistance Market:- Danaher, Abbott, BD, F. Hoffmann-La Roche Ltd, Trinity Biotech, Seimens AG, bioMérieux SA, Bio-Rad Laboratories, Inc, AccuBioTech Co., Ltd., and ACON Laboratories, Inc.

Scope of Antiviral Drug Resistance Market:

The report offers key drivers that propel the growth in the global Antiviral Drug Resistance Market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions.

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Antiviral Drug Resistance Market which would mention How the Covid-19 is Affecting the Disposable Incontinence Products (DIPs) Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Disposable Incontinence Products (DIPs) Players to fight Covid-19 Impact.

Antiviral Drug Resistance Market: Regional analysis includes:
 Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
 Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
 North America (the United States, Mexico, and Canada.)
 South America (Brazil etc.)
 The Middle East and Africa (GCC Countries and Egypt.)

Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 10+ companies.

Purchase Copy of This Report at: https://bit.ly/3Ba2Fx0

...

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

Contact US
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
E-mail: sales@theinsightpartners.com

This release was published on openPR.